Table 1 Summary of the patients' clinical signs and symptoms.
Clinical characteristic | Patient | |
---|---|---|
SD600 | SD840 | |
Sex | Male | Male |
Dysmorphism | ||
Broad low nasal bridge | Yes | Yes |
Bulbous nasal tip | Yes | Yes |
Microdontia | Yes | Yes |
Hyperpigmented macules | Yes | Yes |
Lumbar lordosis | Yes | Yes |
Protuberant abdomen | Yes | Yes |
Skeleton and growth | ||
Poor growth | Yes | Yes |
Disproportionate short stature | Yes | Yes |
Spondyloepiphysial dysplasia | Yes | Yes |
Degenerative hip disease | Yes | Yes |
Development | ||
Normal cognitive, motor, language, social development | Yes | Yes |
Normal school performance | Yes | Yes |
Endocrinology | ||
Raised level of thyroid‐stimulating hormone | No | No |
Haematology | ||
Lymphopenia | Yes | Yes |
Neutropenia | Yes | No |
Anaemia | Yes | No |
Thrombocytopenia | Yes | No |
Immunology | ||
Recurrent infections | No | Yes |
Circulating T cell deficiency | Yes | Yes |
Circulating B cell deficiency | No | NC |
Hypogammaglobulnaemia | Yes | No |
Nephrology | ||
FSGS | Yes | Yes |
Progressive renal failure | Yes | Yes |
Renal transplant | Yes | Yes |
Donor age (years) | 46 | 15 |
Hypertension before transplant | Yes | Yes |
Hypertension after transplant | Yes | Yes |
Neurology | ||
TIAs | Yes | Yes |
Strokes | Yes | No |
Migraines | No | Yes |
Pulmonary | ||
Pulmonary hypertension | Yes | Yes |
Dyspnoea | No | Yes |
Genetics | ||
Normal karyotype | Yes | NC |
SMARCAL1 mutations | ||
Paternal allele | 2542G→T E848X | 1248‐9insC T417fs427X |
Maternal allele | 2542G→T E848X | 2104T→G F702V |
FSGS, focal segmental glomerulosclerosis; NC, not countable; SMARCAL1, swi/snf‐related matrix‐associated actin‐dependent regulator of chromatin, subfamily a‐like 1; TIA, transient ischaemic attack.